Johnson & Johnson, US4781601046

Johnson & Johnson stock trades on the New York Stock Exchange

Published on 07/11/2026 at 11:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson stock remains a large-cap health care name on the NYSE, with the company focused on medicines, medtech, and consumer health heritage.

Johnson & Johnson, US4781601046, Illustration mit AI erstellt.
Johnson & Johnson, US4781601046, Illustration mit AI erstellt.

Johnson & Johnson (ISIN US4781601046) trades on the New York Stock Exchange and remains one of the largest health care companies in the United States.

Core business

The company operates through pharmaceuticals and medtech, with a long operating history and broad exposure to hospital, surgeon, and patient care spending.

Market context

For U.S. investors, that makes Johnson & Johnson part of the defensive large-cap health care group, where earnings quality and product mix often matter more than short-term sentiment.

Product focus

Representative products include Stelara, Darzalex, and the companys medtech portfolio, which spans surgery, orthopaedics, and vision care.

Stock context

Johnson & Johnson shares trade on the NYSE in U.S. dollars. As of July 11, 2026, the stock price was not provided in the available search results.

Fact box

  • Company: Johnson & Johnson
  • ISIN: US4781601046
  • Ticker: JNJ
  • Exchange: NYSE
  • Sector / Industry: Health Care / Pharmaceuticals

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US4781601046 | JOHNSON & JOHNSON | boerse | 69743248 | bgmi